Found 16 matching trials
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
PHASE2This is a multicenter, open-label, prospective, single-arm, phase II study ...
Location
Fujian Medical University Union Hospital
The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung Cancer
N/ATo determine the optimal objective response rate (ORR) of tislelizumab comb...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Guangzhou Medical University
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
PHASE1The primary objectives of this study were: to assess the safety and tolerab...
Location
Mayo Clinic Phoenix
Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC
PHASE2To explore the related biomarkers for safety and efficacy of the combinatio...
Location
Guangzhou Medical University Affiliated Cancer Hospital
Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base
PHASE2This prospective, single-arm, Phase II clinical trial aims to evaluate the ...
Location
Hospital of Stomatology, Sun Yat-sen University
Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage โ
ข Unresectable Non-small Cell Lung Cancer
PHASE4Explorative study, which evaluates the effect of Tislelizumab combined with...
Location
the Affiliated Hospital of Qingdao University
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
PHASE2This is a randomized controlled, phase II clinical study designed to explor...
Location
Shanghai First People's Hospital
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study
N/AEsophageal squamous cell carcinoma (ESCC) is highly prevalent in China, wit...
Location
Multiple Locations
Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage โ
ข NSCLC
PHASE2The purpose of this conversion therapy study is to evaluate the safety and ...
Location
Beijing Tsinghua Chang Gung Hospital
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors
PHASE1The primary objective of this study is to assess the safety and tolerabilit...
Location
Icahn School of Medicine At Mount Sinai